|
#Unite2FightCorona #IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
*****
India’s Active caseload falls to 33,917 today; stands at 0.08% of India’s total Positive Cases
2,568 new cases reported in the last 24 hours
India’s Cumulative COVID-19 Vaccination Coverage exceeds 180.40 Cr
Recovery Rate currently stands at 98.72%
Weekly Positivity Rate is presently at 0.46%
In a positive development, India’s Active Caseload has declined to 33,917. Active cases now constitute 0.08% of the country’s total Positive Cases.
Consequently, India’s recovery rate stands at 98.72%. 4,722 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,24,46,171.
2,568 new cases were reported in the last 24 hours.
The last 24 hours saw a total of 7,01,773 COVID-19 tests being conducted. India has so far conducted over 77.97 Cr (77,97,54,156) cumulative tests.
There has been a sustained fall in the weekly and daily Positivity Rates too. Weekly Positivity Rate in the country currently stands at 0.46% and the Daily Positivity rate is reported to be 0.37%.
On the vaccination front, India’s COVID-19 vaccination coverage has exceeded 180.40 Cr (1,80,40,28,891) as per provisional reports till 7 am today. This has been achieved through 2,11,52,628 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:
Cumulative Vaccine Dose Coverage | ||
HCWs | 1st Dose | 1,04,02,731 |
2nd Dose | 99,85,923 | |
Precaution Dose | 43,21,775 | |
FLWs | 1st Dose | 1,84,11,615 |
2nd Dose | 1,74,80,218 | |
Precaution Dose | 65,82,840 | |
Age Group 15-18 years | 1st Dose | 5,59,68,909 |
2nd Dose | 3,43,09,111 | |
Age Group 18-44 years | 1st Dose | 55,34,55,646 |
2nd Dose | 45,64,67,364 | |
Age Group 45-59 years | 1st Dose | 20,25,55,219 |
2nd Dose | 18,30,29,983 | |
Over 60 years | 1st Dose | 12,66,05,098 |
2nd Dose | 11,39,94,240 | |
Precaution Dose | 1,04,58,219 | |
Precaution Dose | 2,13,62,834 | |
Total | 1,80,40,28,891 |
https://pib.gov.in/PressReleasePage.aspx?PRID=1806021
Update on COVID-19 Vaccine Availability in States/UTs
More than 182.84 Crore vaccine doses provided to States/UTs
More than 17.30 Crore balance and unutilized vaccine doses still available with States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
VACCINE DOSES |
(As on 15th March 2022) |
SUPPLIED |
1,82,84,94,230 |
BALANCE AVAILABLE
|
17,30,61,681 |
More than 182.84 crore (1,82,84,94,230) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.
More than 17.30 Cr (17,30,61,681) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
https://pib.gov.in/PressReleasePage.aspx?PRID=1806009
COVID19 Vaccination for 12-14 yrs cohort to begin from tomorrow, National Vaccination Day, in all States/UTs
Free-of-Cost vaccination for 12-14 yrs age Group to begin in Govt COVID Vaccination Centers
States/UTs to ensure only those above 12 years are administered COVID19 Vaccine
Adequate vaccines available; Proactively cover Vulnerable Population above 60 yrs of age
Free of cost COVID19 vaccination for all beneficiaries of 12-14 age group will begin from tomorrow (16th March 2022), National Vaccination Day, at all Government COVID Vaccination Centers. The COVID19 vaccine to be administered would be Corbevax manufactured by Biological E. Limited, Hyderabad. This can be through online registration (beginning 9 am on 16th March 2022) or through onsite walk-in. This was reiterated by Union Health Secretary, Shri Rajesh Bhushan in a meeting through video conference (VC) today with all States and UTs.
This follows the decision of Union Government to start COVID19 vaccination for 12-13 yr and 13-14 yr age groups (those born in 2008, 2009 and 2010. i.e. those who are already above 12 years of age) from 16th March 2022. Additionally, all above 60 years of age are now eligible for Precaution Dose from tomorrow, as the condition of comorbidity for this age group has been removed. The Precaution Dose (same as the previous two doses) is to be administered after 9 months (36 weeks) after the date of second vaccination. Detailed instructions and Operational Guidelines have been sent to States and UTs in this regard.
States were advised to ensure that only those who have attained the age of 12 years on the date of vaccination are vaccinated against COVID19; if the beneficiary is registered but not attained the age of 12 years on the date of vaccination, COVID19 vaccine is not to be given. Vaccinators and vaccination teams need to be trained to ensure that particularly for 12-14 years age group there is no mixing of vaccines. States were advised to organize dedicated vaccination sessions through earmarked COVID-19 Vaccination Centers for vaccination of 12-14 years’ age-group to avoid mixing with other vaccines.
Vaccines that can be used in different age groups
Age Group | Vaccine to be used |
12-14 years (All beneficiaries born in year 2008, 2009, 2010) | Corbevax (at Govt. CVCs), 2 doses at interval of 28 days |
14-18 years | Covaxin (at Govt. CVCs and Pvt. CVCs)
|
States/UTs were informed that at present the age of beneficiary in CoWIN is being filtered based on Year of Birth. The responsibility for verification of age (12 years) will lie with the vaccinator/verifier at the time of vaccination for the first few days as the provision for recording the exact Date of Birth in Co-WIN portal is under process. Once implemented, the system, by default, will not allow registration of beneficiaries who are not of the recommended age.
Underscoring slow pace of vaccination among the vulnerable groups, States were urged to ensure that all those above 60 years of age are covered with both doses of COVID19 vaccine. Regular reviews to be conducted at District & Block levels to ensure coverage of eligible beneficiaries.
Sates were also advised to ensure judicious utilization of available COVID19 vaccines. As per earlier guidelines, States can replace those that are due for expiry and also replace them from one district within the State to another to ensure that vaccines are not wasted.
- Manohar Agnani, Addl.Secy (Health) and other senior officers of Union Health Ministry were present in the virtual meeting along with Health Secretary and NHM Mission Directors and other officials from States/UTs.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1806104
TWEET LINKS
COVID-19 Testing Update. For more details visit: https://t.co/dI1pqwfJH7 @MoHFW_INDIA @DeptHealthRes @PIB_India @mygovindia @COVIDNewsByMIB #ICMRFIGHTSCOVID19 #IndiaFightsCOVID19 #CoronaUpdatesInIndia #COVID19 #Unite2FightCorona pic.twitter.com/1k021VOo5j
— ICMR (@ICMRDELHI) March 15, 2022
#LargestVaccineDrive#Unite2FightCorona pic.twitter.com/W9PvJQX4bA
— Ministry of Health (@MoHFW_INDIA) March 15, 2022